Cargando…
Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises
Different approaches have been utilized or proposed for the treatment of lysosomal storage disorders (LSDs) including enzyme replacement and hematopoietic stem cell transplant therapies, both aiming to compensate for the enzymatic loss of the underlying mutated lysosomal enzymes. However, these appr...
Autores principales: | Mohamed, Fedah E., Al-Gazali, Lihadh, Al-Jasmi, Fatma, Ali, Bassam R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500627/ https://www.ncbi.nlm.nih.gov/pubmed/28736525 http://dx.doi.org/10.3389/fphar.2017.00448 |
Ejemplares similares
-
LINS, a modulator of the WNT signaling pathway, is involved in human cognition
por: Akawi, Nadia A, et al.
Publicado: (2013) -
Degradation routes of trafficking-defective VLDLR mutants associated with Dysequilibrium syndrome
por: Kizhakkedath, Praseetha, et al.
Publicado: (2018) -
Chaperones and Proteostasis: Role in Parkinson’s Disease
por: Joshi, Neha, et al.
Publicado: (2020) -
Ribosome-associated chaperones act as proteostasis sentinels
por: Kirstein-Miles, Janine, et al.
Publicado: (2013) -
Proteostasis Regulators
in Cystic Fibrosis: Current
Development and Future Perspectives
por: Brusa, Irene, et al.
Publicado: (2022)